Host–Bacterial Crosstalk Determines Staphylococcus aureus Nasal Colonization

Trends in Microbiology

Volumn 24, Issue 11, 2016, Pages 872-886

  Mulcahy, Michelle E ^a   McLoughlin, Rachel M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

nasal colonization; Staphylococcus aureus

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 3; C REACTIVE PROTEIN; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; LORICRIN; MANNOSE BINDING LECTIN; SCAVENGER RECEPTOR C; SCAVENGER RECEPTOR C 1; STAPHYLOCOCCUS PROTEIN A; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBIOSIS; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BACTERIUM CARRIER; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOREGULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; INTESTINE FLORA; NONHUMAN; NOSE MUCOSA; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; TH1 CELL; TH17 CELL; ANIMAL; DIAGNOSIS; DISEASE MODEL; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; NOSE; NOSE CAVITY; ORGANISMAL INTERACTION; PATHOGENICITY; PHYSIOLOGY; RODENT; STAPHYLOCOCCUS INFECTION; TRANSMISSION;

ADAPTIVE IMMUNITY; ANIMALS; BACTERIAL ADHESION; CARRIER STATE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICROBIAL INTERACTIONS; MICROBIOTA; NASAL CAVITY; NASAL MUCOSA; NOSE; RISK FACTORS; RODENTIA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84994507697     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.06.012     Document Type: Review

References (100)

1. 1 van Belkum, A., et al. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199 (2009), 1820–1826.
2. 2 von Eiff, C., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N. Engl. J. Med. 344 (2001), 11–16.
3. 3 Wertheim, H.F., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364 (2004), 703–705.
4. 4 Emonts, M., et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197 (2008), 1244–1253.
5. 5 Nurjadi, D., et al. Impaired beta-defensin expression in human skin links DEFB1 promoter polymorphisms with persistent Staphylococcus aureus nasal carriage. J. Infect. Dis. 207 (2013), 666–674.
6. 6 Ruimy, R., et al. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans?. J. Infect. Dis. 202 (2010), 924–934.
7. 7 Zanger, P., et al. Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo. Infect. Immun. 79 (2011), 2658–2662.
8. 8 Vuononvirta, J., et al. Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants. PLoS ONE, 6, 2011, e26198.
9. 9 van den Akker, E.L., et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J. Infect. Dis. 194 (2006), 814–818.
10. 10 Messaritakis, I., et al. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 2 diabetes. Clin. Microbiol. Infect. 20 (2014), 920–925.
11. 11 Kotpal, R., et al. Incidence and risk factors of nasal carriage of Staphylococcus aureus in HIV-infected individuals in comparison to HIV-uninfected individuals: a case-control study. J. Int. Assoc. Provid. AIDS Care 15 (2016), 141–147.
12. 12 Breuer, K., et al. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 147 (2002), 55–61.
13. 13 Bassetti, S., et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J. Rheumatol. 32 (2005), 2125–2129.
14. 14 Colque-Navarro, P., et al. Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population. Clin. Vaccine Immunol. 17 (2010), 1117–1123.
15. 15 Swierstra, J., et al. IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction. Infect. Immun. 83 (2015), 492–501.
16. 16 Verkaik, N.J., et al. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis. 199 (2009), 625–632.
17. 17 Holtfreter, S., et al. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 193 (2006), 1275–1278.
18. 18 Kolata, J., et al. Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 11 (2011), 3914–3927.
19. 19 Holtfreter, S., et al. Human immune proteome in experimental colonization with Staphylococcus aureus. Clin. Vaccine Immunol. 16 (2009), 1607–1614.
20. 20 Verkaik, N.J., et al. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin. Microbiol. Infect. 16 (2010), 1312–1317.
21. 21 Baur, S., et al. A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization. PLoS Pathog., 10, 2014, e1004089.
22. 22 Mulcahy, M.E., et al. Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog., 8, 2012, e1003092.
23. 23 Candi, E., et al. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6 (2005), 328–340.
24. 24 Clarke, S.R., et al. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect. Immun. 77 (2009), 2408–2416.
25. 25 Clarke, S.R., et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J. Infect Dis. 193 (2006), 1098–1108.
26. 26 Wertheim, H.F., et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med., 5, 2008, e17.
27. 27 Schaffer, A.C., et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect. Immun. 74 (2006), 2145–2153.
28. 28 O'Brien, L.M., et al. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol. 4 (2002), 759–770.
29. 29 Haim, M., et al. Cytokeratin 8 interacts with clumping factor B: a new possible virulence factor target. Microbiology 156:Pt 12 (2010), 3710–3721.
30. 30 Son, E.D., et al. Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion. J. Dermatol. Sci. 74 (2014), 64–71.
31. 31 Rolle, C.E., et al. Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A. Immunol. Res. 57 (2013), 258–267.
32. 32 Boniface, K., et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174 (2005), 3695–3702.
33. 33 Wolk, K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36 (2006), 1309–1323.
34. 34 Mulcahy, M.E., et al. Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. Mucosal Immunol, 2016, 10.1038/mi.2016.24 Published online March 23, 2016.
35. 35 Nograles, K.E., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159 (2008), 1092–1102.
36. 36 Weidenmaier, C., et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10 (2004), 243–245.
37. 37 Weidenmaier, C., et al. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298 (2008), 505–513.
38. 38 Burian, M., et al. Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J. Infect Dis. 201 (2010), 1414–1421.
39. 39 Rechner, C., et al. Host glycoprotein Gp96 and scavenger receptor SREC interact with PorB of disseminating Neisseria gonorrhoeae in an epithelial invasion pathway. Cell Host Microbe 2 (2007), 393–403.
40. 40 Dieudonne, A., et al. Scavenger receptors in human airway epithelial cells: role in response to double-stranded RNA. PLoS ONE, 7, 2012, e41952.
41. 41 Murshid, A., et al. Emerging roles for scavenger receptor SREC-I in immunity. Cytokine 75 (2015), 256–260.
42. 42 Means, T.K., et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206 (2009), 637–653.
43. 43 Beauvillain, C., et al. The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells. J. Hepatol. 52 (2010), 644–651.
44. 44 Winstel, V., et al. Wall teichoic acid glycosylation governs Staphylococcus aureus nasal colonization. mBio, 6, 2015, e00632.
45. 45 Li, M., et al. MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat. Med. 18 (2012), 816–819.
46. 46 Liu, Q., et al. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection. Infect. Immun. 83 (2015), 2168–2174.
47. 47 Corrigan, R.M., et al. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol., 9, 2009, 22.
48. 48 Askarian, F., et al. The interaction between Staphylococcus aureus SdrD and desmoglein 1 is important for adhesion to host cells. Sci. Rep., 6, 2016, 22134.
49. 49 Uehara, Y., et al. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J. Hosp. Infect. 44 (2000), 127–133.
50. 50 Frank, D.N., et al. The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE, 5, 2010, e10598.
51. 51 Bogaert, D., et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363 (2004), 1871–1872.
52. 52 Selva, L., et al. Killing niche competitors by remote-control bacteriophage induction. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 1234–1238.
53. 53 van Gils, E.J., et al. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 29 (2011), 7595–7598.
54. 54 Iwase, T., et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465 (2010), 346–349.
55. 55 Liu, C.M., et al. Staphylococcus aureus and the ecology of the nasal microbiome. Sci. Adv., 1, 2015, e1400216.
56. 56 Ichinohe, T., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 5354–5359.
57. 57 Noverr, M.C., et al. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72 (2004), 4996–5003.
58. 58 Kieper, W.C., et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174 (2005), 3158–3163.
59. 59 Ichinohe, T., et al. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11 (2010), 404–410.
60. 60 McLoughlin, R.M., Mills, K.H., Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J. Allergy Clin. Immunol 127 (2011), 1097–1107 quiz 1108-1109.
61. 61 Fagundes, C.T., et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J. Immunol. 188 (2012), 1411–1420.
62. 62 Gauguet, S., et al. Intestinal microbiota of mice influences resistance to Staphylococcus aureus pneumonia. Infect. Immun. 83 (2015), 4003–4014.
63. 63 Archer, N.K., et al. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect. Immun. 81 (2013), 2070–2075.
64. 64 Planet, P.J., et al. Lambda interferon restructures the nasal microbiome and increases susceptibility to Staphylococcus aureus superinfection. mBio, 2016, 10.1128/mBio.01939-15 Published online February 9, 2016.
65. 65 Midorikawa, K., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71 (2003), 3730–3739.
66. 66 Grone, A., Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88 (2002), 1–12.
67. 67 Simanski, M., et al. IL-17A and IFN-gamma synergistically induce RNase 7 expression via STAT3 in primary keratinocytes. PLoS ONE, 8, 2013, e59531.
68. 68 Mempel, M., et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol. 121 (2003), 1389–1396.
69. 69 Scharf, S., et al. Streptococcus pneumoniae induces human beta-defensin-2 and -3 in human lung epithelium. Exp. Lung Res. 38 (2012), 100–110.
70. 70 Gonzalez-Zorn, B., et al. Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice. Infect. Immun. 73 (2005), 1847–1851.
71. 71 Quinn, G.A., Cole, A.M., Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 122 (2007), 80–89.
72. 72 Choi, S.M., et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3gamma is required for host defense against MRSA pneumonia. J. Exp. Med. 210 (2013), 551–561.
73. 73 Kirchberger, S., et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210 (2013), 917–931.
74. 74 Cole, A.M., et al. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 8 (2001), 1064–1069.
75. 75 Burgey, C., et al. Differential induction of innate defense antimicrobial peptides in primary nasal epithelial cells upon stimulation with inflammatory cytokines, Th17 cytokines or bacterial conditioned medium from Staphylococcus aureus isolates. Microb. Pathog. 90 (2016), 69–77.
76. 76 Cole, A.L., et al. Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriage. Mucosal Immunol, 2016, 10.1038/mi.2016.2 Published online February 3, 2016.
77. 77 Miller, L.S., et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24 (2006), 79–91.
78. 78 Chan, L.C., et al. Nonredundant roles of interleukin-17A (IL-17A) and IL-22 in murine host defense against cutaneous and hematogenous infection due to methicillin-resistant Staphylococcus aureus. Infect. Immun. 83 (2015), 4427–4437.
79. 79 Muthukrishnan, G., et al. Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J. Proteome Res. 10 (2011), 2064–2078.
80. 80 Gemmell, C.G., et al. Susceptibility to opsonophagocytosis of protein-a, alpha-hemolysin and beta-toxin deficient mutants of Staphylococcus aureus isolated by allele-replacement. Staphylococci 21 (1991), 273–277.
81. 81 Palmqvist, N., et al. Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb. Pathogenesis 33 (2002), 239–249.
82. 82 Gomez, M.I., et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10 (2004), 842–848.
83. 83 Giai, C., et al. Shedding of tumor necrosis factor receptor 1 induced by protein A decreases tumor necrosis factor alpha availability and inflammation during systemic Staphylococcus aureus infection. Infect. Immun. 81 (2013), 4200–4207.
84. 84 Thurlow, L.R., et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186 (2011), 6585–6596.
85. 85 Heim, C.E., et al. Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. J. Immunol. 192 (2014), 3778–3792.
86. 86 Tebartz, C., et al. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J. Immunol. 194 (2015), 1100–1111.
87. 87 Peres, A.G., et al. Uncoupling of pro- and anti-inflammatory properties of Staphylococcus aureus. Infect. Immun. 83 (2015), 1587–1597.
88. 88 Neill, D.R., et al. Density and duration of pneumococcal carriage is maintained by transforming growth factor beta 1 and T regulatory cells. Am. J. Resp. Crit. Care Med. 189 (2014), 1250–1259.
89. 89 Nouwen, J.L., et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a “culture rule”. Clin. Infect. Dis. 39 (2004), 806–811.
90. 90 Kaspar, U., et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ. Microbiol, 2015, 10.1111/1462-2920.12891 Published online April 28, 2015.
91. 91 Nakamura, M.M., et al. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J. Clin. Microbiol. 48 (2010), 2957–2959.
92. 92 Ten Broeke-Smits, N.J., et al. Hair follicles as a niche of Staphylococcus aureus in the nose; is a more effective decolonisation strategy needed?. J. Hosp. Infect. 76 (2010), 211–214.
93. 93 Acton, D.S., et al. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?. Eur. J. Clin. Microbiol. Infect. Dis. 28 (2009), 115–127.
94. 94 Mermel, L.A., et al. Methicillin-resistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis. J. Clin. Microbiol. 49 (2011), 1119–1121.
95. 95 Cole, A.M., et al. Innate antimicrobial activity of nasal secretions. Infect. Immun. 67 (1999), 3267–3275.
96. 96 Salgado-Pabon, W., Schlievert, P.M., Models matter: the search for an effective Staphylococcus aureus vaccine. Nat. Rev. Microbiol. 12 (2014), 585–591.
97. 97 Holtfreter, S., et al. Characterization of a mouse-adapted Staphylococcus aureus strain. PLoS ONE, 8, 2013, e71142.
98. 98 Knop, J., et al. Staphylococcus aureus infection in humanized mice: a new model to study pathogenicity associated with human immune response. J. Infect. Dis. 212 (2015), 435–444.
99. 99 Xu, S.X., et al. Superantigens modulate bacterial density during Staphylococcus aureus nasal colonization. Toxins (Basel) 7 (2015), 1821–1836.
100. 100 Johswich, K.O., et al. In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. PLoS Pathog., 9, 2013, e1003509.